SARS-CoV-2 and diabetes : New challenges for the disease
Copyright © 2020 Elsevier B.V. All rights reserved..
A novel small enveloped RNA virus with the typical characteristic of the family to which it belongs, a crown, hence the name coronavirus, appeared in December 2019 in Wuhan, China, and subdued the world to its influence. The particular severity of the disease and higher mortality rates in patients with associated morbidities, including hypertension, obesity and diabetes, increases the concern over the consequences of this pandemic. In this review, the features of SARS-CoV-2 will be addressed, as well as the reasons why it poses a particular challenge to diabetic patients. We will also highlight the recent treatment strategies being explored to control this pandemic. Emerging evidence demonstrates that the correct management of diabetes in those patients infected with SARS-CoV-2 is of utmost importance for the viral disease progression, therefore, the importance of blood glucose control will also be addressed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:164 |
|---|---|
| Enthalten in: |
Diabetes research and clinical practice - 164(2020) vom: 01. Juni, Seite 108228 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cristelo, Cecília [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ACE inhibitors |
|---|
| Anmerkungen: |
Date Completed 09.07.2020 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.diabres.2020.108228 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310289815 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310289815 | ||
| 003 | DE-627 | ||
| 005 | 20231225135756.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.diabres.2020.108228 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1034.xml |
| 035 | |a (DE-627)NLM310289815 | ||
| 035 | |a (NLM)32446801 | ||
| 035 | |a (PII)S0168-8227(20)30478-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cristelo, Cecília |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 and diabetes |b New challenges for the disease |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.07.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier B.V. All rights reserved. | ||
| 520 | |a A novel small enveloped RNA virus with the typical characteristic of the family to which it belongs, a crown, hence the name coronavirus, appeared in December 2019 in Wuhan, China, and subdued the world to its influence. The particular severity of the disease and higher mortality rates in patients with associated morbidities, including hypertension, obesity and diabetes, increases the concern over the consequences of this pandemic. In this review, the features of SARS-CoV-2 will be addressed, as well as the reasons why it poses a particular challenge to diabetic patients. We will also highlight the recent treatment strategies being explored to control this pandemic. Emerging evidence demonstrates that the correct management of diabetes in those patients infected with SARS-CoV-2 is of utmost importance for the viral disease progression, therefore, the importance of blood glucose control will also be addressed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a ACE inhibitors | |
| 650 | 4 | |a ACE-2 | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Glycemic control | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 700 | 1 | |a Azevedo, Cláudia |e verfasserin |4 aut | |
| 700 | 1 | |a Marques, Joana Moreira |e verfasserin |4 aut | |
| 700 | 1 | |a Nunes, Rute |e verfasserin |4 aut | |
| 700 | 1 | |a Sarmento, Bruno |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes research and clinical practice |d 1993 |g 164(2020) vom: 01. Juni, Seite 108228 |w (DE-627)NLM01260335X |x 1872-8227 |7 nnns |
| 773 | 1 | 8 | |g volume:164 |g year:2020 |g day:01 |g month:06 |g pages:108228 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.diabres.2020.108228 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 164 |j 2020 |b 01 |c 06 |h 108228 | ||